Yoko Tsutsumi

Exendin-4, a GLP-1 Receptor Agonist, Attenuates Prostate Cancer Growth

Takashi Nomiyama, Takako Kawanami, Shinichiro Irie et al. · Diabetes · 2014 · 130 citations · Full text

Incretin Drug Exendin, Urology, Chemoprevention Strategy +10

Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-κB Activation

Chikayo Iwaya, Takashi Nomiyama, Shiho Komatsu et al. · Endocrinology · 2017 · 77 citations · Full text

Breast Oncology, Immunology, Cancer Biology +17

Mouse dexamethasone-induced RAS protein 1 gene is expressed in a circadian rhythmic manner in the suprachiasmatic nucleus

Hirokazu Takahashi, Nanae Umeda, Yoko Tsutsumi et al. · Molecular Brain Research · 2003 · 74 citations

Signal Transduction, Alertness, Developmental Biology +12

Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth

Yoko Tsutsumi, Takashi Nomiyama, Takako Kawanami et al. · PLoS ONE · 2015 · 43 citations · Full text

The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis

Yuichi Terawaki, Takashi Nomiyama, Yuko Akehi et al. · Diabetology & Metabolic Syndrome · 2013 · 29 citations · Full text